Nagi Bioscience is part of the 2018 MassChallenge Accelerator Program

We are glad to announce that Nagi is among the 66 high-impact startups that will join the final stage of the MassChallenge acceleration program. Our startup will benefit from world-class mentorship, programming, and resources during for improving our business case. The accelerator program will start in June and culminate on October 30th at the MassChallenge Switzerland Awards Ceremony.

Headquartered in the United States with locations in Boston, Israel, Mexico, Switzerland, Texas, and the UK, MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world for zero-equity taken.

Media coverage in Bilan and StartupTicker.ch.